The CME and pharmaceutical industries received a reprieve when the U.S. Senate failed to take up the Physician Payments Sunshine Act in 2007. But it is likely to be up for a vote in 2008, cautions Thomas P. Sullivan, president, Rockpointe Corp., Columbia, Md. The bill would require pharmaceutical and medical device manufacturers to disclose payments they make to doctors directly, indirectly, or through a third party, including gifts, honoraria, travel, and CME. The information would be ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Sunshine Law Stalls, you'll get exclusive access to a large archive of premium content.

Already registered? here.